It is established that PAX3-SIX2 expression correlates with distinct MuSCs behavior, influencing regeneration rates in a muscle-type-dependent context, and it is suggested that PAX3-SIX2 heterogeneity could be leveraged for targeted therapeutic strategies in muscle-wasting diseases.
Abstract
The human body contains around 640 distinct muscles, each capable of regeneration following injury through the action of muscle-specific stem cells (MuSCs), that express the transcription factor PAX7. Its paralog, PAX3, a master regulator of embryonic myogenesis, is selectively expressed in a subset of adult quiescent MuSCs. The proportion of PAX3-pos MuSCs varies across muscles. By combining lineage tracing and skeletal muscle injury, we demonstrate that PAX3 drives MuSC diversity and muscle-specific regeneration rates. PAX3-expressing MuSCs display enhanced proliferation and differentiation capacities, enabling a faster response following injury, whereas loss of PAX3 leads to proliferation arrest and cell death. Single-cell RNA-sequencing analyses revealed the specific expression of Six2 in PAX3-pos MuSCs. We show that PAX3 is required for SIX2 expression, and loss of SIX2 in MuSCs reduces proliferation and differentiation rates. Conversely, ectopic Six2 expression promotes proliferation of PAX3-neg MuSCs by directly activating cell cycle pathways. With this work, we establish that PAX3-SIX2 expression correlates with distinct MuSCs behavior, influencing regeneration rates in a muscle-type-dependent context. Our findings highlight a previously unrecognized layer of regulation in MuSC behaviour and muscle repair and suggest that PAX3-SIX2 heterogeneity could be leveraged for targeted therapeutic strategies in muscle-wasting diseases.
By challenging myogenesis with double knockout of both YAP and TAZ, the unmasked regenerative requirements previously undetected in single-gene loss models, highlighting genetic redundancy as a key principle buffering regenerative robustness.
Jason S. Silver, Alicia A. Cutler, Tze-Ling Chang et al.· bioRxiv· 0 citations
By defining the age-associated fate of MuSC fusion to muscle fibers, it is provided potential targets for modulating muscle plasticity and predicts Runx1 may function as a master regulator of MuSC-Derived myonuclear specialization in response to MOV.
Nicholas T. Thomas, Jensen Goh, Kevin A. Murach et al.· bioRxiv· 0 citations
Molecular, cellular, and niche-level evidence across these settings are integrated to explain why FGF signaling produces divergent outcomes and to clarify how cellular context and timing should inform therapeutic modulation.
Skeletal muscle maintenance and regeneration are highly regulated by cell fate decisions made by muscle stem cells and their progeny, myoblasts. Although the transcription factor p53 is well known for its role in cellular stress responses, cell cycle regulation, and tumor prevention, emerging evidence suggests that p53...
Ingrid R. Aragon, Neha Patole, Ajay Vachanaram et al.· Frontiers in Cell and Develo...· 0 citations
It is suggested that mesenchymal progenitor cells do not commit to a myogenic fate during cancer cachexia, and non-myogenic progenitors might indeed be capable of adopting a myogenic fate during cancer cachexia.
Spencer G. Miller, Abasi-Ama Udeme, Emma Funk et al.· American Journal of Physiolo...· 0 citations
Muscle stem cells (MuSCs) represent a subset of satellite cells (SCs) and constitute the stem cell compartment of the skeletal muscle tissue. MuSCs and SCs are quiescent under homeostatic conditions but activate upon injury to drive regeneration and repopulation of the stem cell pool. Heterogeneity has become a central...
O. Ashekyan, Marie J. Catenacci, Corentin Guilhot et al.· Frontiers in Cell and Develo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.